Ensuring the Rigor of Regulatory Science: CDER Conducts Laboratory and Clinical Studies to Investigate Reports of NDMA Production from Ingested Ranitidine Products

Ranitidine, which blocks histamine-induced acid secretion in the stomach, was approved in 1983. It became widely used over the ensuing decades as a prescription and over-the-counter product.

Source: FDA Center for Drug Evaluation and Research - What's New - July 2, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news